Location History:
- Komae, JP (1997 - 1998)
- Tokyo, JP (1997 - 1999)
Company Filing History:
Years Active: 1997-1999
Title: Innovator Spotlight: Keiichiro Okabe - Revolutionizing Transdermal Drug Delivery
Introduction:
Keiichiro Okabe, a pioneering inventor based in Tokyo, Japan, has made significant contributions to the field of transdermal drug delivery. With a total of 8 patents to his name, Okabe's innovative approach has paved the way for more effective and reliable methods of administering medications through the skin.
Latest Patents:
Among his latest patents is the groundbreaking "Iontophoretic Transdermal Drug-Delivery Interface and Skin Treatment." This patent describes a stabilized interface for iontophoresis, a process that uses electrical currents to enhance the delivery of drugs through the skin. By incorporating a mixture of water-soluble proteins and drugs into a specialized matrix, Okabe has developed a system that ensures optimal drug retention and precise delivery, particularly for physiologically active peptides and proteins.
Career Highlights:
Throughout his career, Okabe has lent his expertise to leading companies in the industry, including Kabushiki Kaisya Advance and Hisamitsu Pharmaceutical Company, Inc. His dedication to innovation and commitment to improving healthcare technologies have garnered recognition within the pharmaceutical community.
Collaborations:
Okabe has collaborated closely with esteemed coworkers such as Toyoji Hibi and Katsumi Iga. Together, they have worked on various projects aimed at advancing drug delivery systems and enhancing patient outcomes. Their combined efforts have led to the development of cutting-edge solutions that continue to shape the future of transdermal drug delivery.
Conclusion:
Keiichiro Okabe's inventive spirit and relentless pursuit of excellence have established him as a trailblazer in the field of transdermal drug delivery. His patents and collaborations underscore his impact on the industry, setting a high standard for innovation and pushing the boundaries of what is possible in pharmaceutical technology.